Permanent phenotypic correction of Haemophilia B in immunocompetent mice by prenatal gene therapy

被引：0
|
作者：
Waddington, SN
Nivsarkar, M
Mistry, A
Buckley, SMK
Kemball-Cook, G
Mosley, KL
Mitrophanous, K
Radcliffe, P
Holder, M
Brittan, M
Georgiadis, T
Al-Allaf, F
Bigger, B
Gregory, L
Cook, HT
Ali, RR
Thrasher, A
Tuddenham, EGD
Themis, M
Coutelle, C
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Gene Therapy Res Grp, Sect Cell & Mol Biol, London SW7 2AZ, England
[2] Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England
[3] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England
[4] Univ London Imperial Coll Sci Technol & Med, Fac Med, Renal Med Sect, London W12 0NN, England
[5] Oxford BioMed UK Ltd, Oxford OX4 4GA, England
[6] Canc Res UK, Histopathol Unit, London WC2A 3PX, England
[7] UCL, Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England
来源：
JOURNAL OF GENE MEDICINE | 2004年 / 6卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
42
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [41] Functional requirements for phenotypic correction of murine β-thalassemia:: implications for human gene therapy
    Persons, DA
    Allay, ER
    Sabatino, DE
    Kelly, P
    Bodine, DM
    Nienhuis, AW
    BLOOD, 2001, 97 (10) : 3275 - 3282
  • [42] Breaking ground in haemophilia B gene therapy: insights from the HOPE-B trial and beyond
    Ozelo, Margareth
    LANCET HAEMATOLOGY, 2024, 11 (04): : e243 - e244
  • [43] Vector clearance following administration of fidanacogene elaparvovec gene therapy in adults with haemophilia B
    Frenzel, L.
    Alzahrani, H.
    Cuker, A.
    Wang, J. -D.
    Fuiman, J.
    Sun, P.
    McKay, J.
    Biondo, F.
    Gaitonde, P.
    Smith, J.
    Kalac, M.
    Rupon, J.
    Plonski, F.
    HAEMOPHILIA, 2024, 30 : 101 - 102
  • [44] Liver-directed gene therapy for haemophilia B with immune stealth lentiviral vectors
    Milani, M.
    Annoni, A.
    Liu, T.
    Bartolaccini, S.
    Biffi, M.
    Russo, F.
    Peters, R.
    Lombardo, A.
    Nichols, T.
    Ayuso, E.
    Cantore, A.
    Naldini, L.
    HUMAN GENE THERAPY, 2017, 28 (12) : A13 - A14
  • [45] Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated review
    Ay, Cihan
    Frenzel, Laurent
    Pinachyan, Karen
    Le Quellec, Sandra
    HAEMOPHILIA, 2024, 30 (01) : 5 - 15
  • [46] AAV mediated gene therapy for haemophilia B: From the early attempts to modern trials
    Muczynski, Vincent
    Nathwani, Amit C.
    THROMBOSIS RESEARCH, 2024, 236 : 242 - 249
  • [47] Phenotypic Correction by AAV8 Gene Therapy of a Mouse Model of Wilson Disease
    Greig, Jenny A.
    Nordin, Jayme M. L.
    Smith, Melanie K.
    Draper, Christine
    Zhu, Yanqing
    Bell, Peter
    Buza, Elizabeth L.
    Wilson, James M.
    MOLECULAR THERAPY, 2018, 26 (05) : 384 - 384
  • [48] Phenotypic correction and stable expression of factor VIII in hemophilia A mice by embryonic stem cell therapy
    Wang, J. J.
    Kuang, Y.
    Zhang, L. L.
    Shen, C. L.
    Wang, L.
    Lu, S. Y.
    Lu, X. B.
    Fei, J.
    Gu, M. M.
    Wang, Z. G.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (02) : 1511 - 1521
  • [49] Gene therapy of RAG-2-/- mice:: sustained correction of the immunodeficiency
    Yates, F
    Malassis-Séris, M
    Stockholm, D
    Bouneaud, C
    Larousserie, F
    Noguiez-Hellin, P
    Danos, O
    Kohn, DB
    Fischer, A
    de Villartay, JP
    Cavazzana-Calvo, M
    BLOOD, 2002, 100 (12) : 3942 - 3949
  • [50] Correction of obesity and diabetes in genetically obese mice by leptin gene therapy
    Muzzin, P
    Eisensmith, RC
    Copeland, KC
    Woo, SLC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) : 14804 - 14808
12345